Page last updated: 2024-10-25

diazepam and Genetic Diseases, Inborn

diazepam has been researched along with Genetic Diseases, Inborn in 1 studies

Diazepam: A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.
diazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5.

Genetic Diseases, Inborn: Diseases that are caused by genetic mutations present during embryo or fetal development, although they may be observed later in life. The mutations may be inherited from a parent's genome or they may be acquired in utero.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Laitinen, L1
Toivakka, E1

Other Studies

1 other study available for diazepam and Genetic Diseases, Inborn

ArticleYear
Clonazepam (Ro 5-4023) in the treatment of myoclonus epilepsy. Four case reports.
    Acta neurologica Scandinavica. Supplementum, 1973, Volume: 53

    Topics: Adult; Anticonvulsants; Benzodiazepinones; Chlorobenzenes; Diazepam; Drug Therapy, Combination; Elec

1973